Meet Jeuveau™ (prabotulinumtoxinA-xvfs) injection–a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a period of time (temporary).
The name that rhymes with “hello”
Jeuveau™ (pronounced Jū vō) comes from the French word “nouveau,” which means “new” or “modern.”
Proven molecular structure
Jeuveau™ is a 900kDa purified botulinum toxin type A.
Made through a modern manufacturing process.
Aesthetic-first and only
Clinically developed only for aesthetics, Jeuveau™ is dedicated exclusively to aesthetics and nothing else.
A new injectable treatment for frown lines is here (oh hey, FDA approval)!
Thanks to science, there’s help for moderate to severe glabellar lines. What’s a glabellar line? Those pesky little wrinkles between your eyebrows that won’t go away—aka frown lines. Meet Jeuveau™—a new FDA-approved injectable treatment that temporarily improves the look of frown lines in adults.
What exactly is Jeuveau™?
You know those pesky little wrinkles between your eyebrows that won’t go away? Well, they’re called glabellar lines, or “frown lines.” Jeuveau™ is an injectable treatment that works to temporarily improve the appearance of moderate to severe frown lines in adults.
What are the results with Jeuveau™?
In our 2 major clinical trials, when we checked at the 30-day mark, 67.5% of patients in 1 study and 70.4% of subjects in a second study were responders defined as a 2-point composite improvement agreed upon by physician and patient.
How does Jeuveau™ work?
Jeuveau™ prevents your nerves from telling your facial muscles to flex. The result? In clinical trials, Jeuveau™ was shown to temporarily improve the appearance of moderate to severe frown lines. In 2 long-term safety studies, patients received an average of 3 treatments over the course of 1 year.
What’s it like before and after treatment?
For specific instructions on what to do before and after your injection, please follow the instructions as given to you by your doctor or healthcare provider.
Studied in numbers
Jeuveau™ has been studied in over 2,100 patients across 5 clinical studies. The most commonly reported side effects in clinical trials include headache, eyelid drooping, upper respiratory tract infection and increased white blood cell count. No serious drug-related adverse events were observed in the studies.